Penumbra
PEN
#1660
Rank
NZ$17.56 B
Marketcap
$456.15
Share price
-2.43%
Change (1 day)
20.48%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total debt

Total debt on the balance sheet as of December 2024 : NZ$0.39 Billion

According to Penumbra's latest financial reports the company's total debt is NZ$0.39 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Penumbra - Total debt on balance sheet (from 2018 to 2024)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.39 B6.89%
2023-12-31NZ$0.37 B-0.21%
2022-12-31NZ$0.37 B46.16%
2021-12-31NZ$0.25 B137.24%
2020-12-31NZ$0.10 B-12.35%
2019-12-31NZ$0.12 B
2018-12-31N/A
2013-12-31NZ$7.3 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$57.27 M-85.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.39 B 255.73%๐Ÿ‡บ๐Ÿ‡ธ USA